We are live on ! Find out more
OCA

OpenArc Corporate Advisory Portfolio holdings

AUM $8.41B
This Fund
S&P 500
This Quarter Est. Return
+16.96%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$8.41B
AUM Growth
+$1.42B
Cap. Flow
+$539M
Cap. Flow %
6.42%
Top 10 Hldgs %
33.46%
Holding
833
New
117
Increased
380
Reduced
255
Closed
44

Sector Composition

Rank Sector Weight
1 Technology 16.24%
2 Consumer Discretionary 5.63%
3 Healthcare 3.98%
4 Industrials 3.9%
5 Communication Services 3.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTEB icon
301
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.8B
$1.36M 0.02%
26,924
-5,609
-17% -$282K
MO icon
302
Altria Group
MO
$114B
$1.35M 0.02%
18,732
+2,731
+17% +$191K
RIO icon
303
Rio Tinto
RIO
$174B
$1.35M 0.02%
14,182
+1,907
+16% +$193K
COR icon
304
Cencora
COR
$62.6B
$1.34M 0.02%
4,738
-2,110
-31% -$608K
GPIX icon
305
Goldman Sachs ETF Trust Goldman Sachs S&P 500 Premium Income ETF
GPIX
$5.44B
$1.34M 0.02%
24,031
+102
+0.4% +$5.53K
PFE icon
306
Pfizer
PFE
$163B
$1.31M 0.02%
54,563
+5,818
+12% +$152K
PRU icon
307
Prudential Financial
PRU
$41.5B
$1.31M 0.02%
12,111
+4,372
+56% +$445K
TOPT
308
iShares Top 20 U.S. Stocks ETF
TOPT
$668M
$1.27M 0.02%
38,730
+4,146
+12% +$135K
DHR icon
309
Danaher
DHR
$152B
$1.26M 0.02%
6,615
+1,165
+21% +$212K
SHOP icon
310
Shopify
SHOP
$198B
$1.26M 0.02%
11,015
-822
-7% -$93.8K
BSX icon
311
Boston Scientific
BSX
$72.3B
$1.25M 0.01%
29,374
-90,412
-75% -$4.91M
XLE icon
312
State Street Energy Select Sector SPDR ETF
XLE
$40.8B
$1.22M 0.01%
23,026
+4,695
+26% +$268K
SUSC icon
313
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.3B
$1.22M 0.01%
52,667
-6,981
-12% -$161K
VRTX icon
314
Vertex Pharmaceuticals
VRTX
$140B
$1.19M 0.01%
2,397
+2
+0.1% +$886
SHEL icon
315
Shell
SHEL
$254B
$1.19M 0.01%
15,293
+2,657
+21% +$229K
HYEM icon
316
VanEck Emerging Markets High Yield Bond ETF
HYEM
$523M
$1.19M 0.01%
58,965
+5,245
+10% +$105K
VOE icon
317
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.4B
$1.15M 0.01%
5,841
+139
+2% +$26.9K
RACE icon
318
Ferrari
RACE
$74.1B
$1.15M 0.01%
3,091
-367
-11% -$128K
CVS icon
319
CVS Health
CVS
$119B
$1.15M 0.01%
11,120
+5,022
+82% +$448K
CMDY icon
320
iShares Bloomberg Roll Select Commodity Strategy ETF
CMDY
$651M
$1.15M 0.01%
20,746
SCHX icon
321
Schwab US Large- Cap ETF
SCHX
$74B
$1.14M 0.01%
38,675
+6,271
+19% +$179K
VFH icon
322
Vanguard Financials ETF
VFH
$13.9B
$1.13M 0.01%
8,615
-2
-0% -$255
SNDK
323
Sandisk
SNDK
$217B
$1.13M 0.01%
+495
New +$707K
BBVA icon
324
Banco Bilbao Vizcaya Argentaria
BBVA
$160B
$1.12M 0.01%
44,705
+8,826
+25% +$201K
JEPI icon
325
JPMorgan Equity Premium Income ETF
JEPI
$46.5B
$1.12M 0.01%
19,808
+8,369
+73% +$473K

Similar funds

OpenArc Corporate Advisory's Q2 2026 Portfolio in Review

As of Q2 2026, OpenArc Corporate Advisory held 833 positions worth $8.41B, up 20% from $6.98B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

OpenArc Corporate Advisory deployed $539M of net new capital in Q2 2026, opening 117 new positions and adding to 380 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 437,245 shares worth $179M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares A.I. Innovation and Tech Active ETF, an estimated $119M trimmed.

  • OpenArc Corporate Advisory's largest Q2 2026 buy was iShares Russell 1000 ETF: 437,245 shares worth $179M.
  • OpenArc Corporate Advisory added most to Vanguard Russell 1000 Value ETF in Q2 2026, an estimated $55.3M increase.
  • OpenArc Corporate Advisory's biggest Q2 2026 reduction was iShares A.I. Innovation and Tech Active ETF, cutting an estimated $119M.
  • OpenArc Corporate Advisory fully exited Kiniksa Pharmaceuticals in Q2 2026, selling an estimated $2.33M.
  • OpenArc Corporate Advisory's ten largest holdings make up 33% of its $8.41B portfolio in Q2 2026.
  • OpenArc Corporate Advisory opened 117 new positions and closed 44 in Q2 2026.
  • OpenArc Corporate Advisory's portfolio value rose 20% quarter-over-quarter to $8.41B.

Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.